MedTrace Logo

Inspiratory Flow Parameters of Easyhaler and Diskus Inhalers (SALIF)

NCT01424137 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 227

Last updated 2012-02-03

No results posted yet for this study

Summary

The purpose of this study is to characterise inspiratory flow parameters across 2 Easyhaler® (EH) inhaler versions and Diskus® inhaler in patients with asthma (including children, adults, and the elderly) and in patients with chronic obstructive pulmonary disease (COPD).

Conditions

Interventions

DEVICE

Easyhaler type A

Easyhaler type A inhaler, 3 consecutive inhalations

DEVICE

Easyhaler type B

Easyhaler type B inhaler, 3 consecutive inhalations

DEVICE

Diskus inhaler

Diskus inhaler, 3 consecutive inhalations

Sponsors & Collaborators

  • Orion Corporation, Orion Pharma

    lead INDUSTRY

Principal Investigators

  • Kati Kaijasilta · Orion Corporation, Orion Pharma

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
4 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2011-11-30
Completion
2011-11-30

Countries

  • Estonia
  • Finland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01424137 on ClinicalTrials.gov